Tikvah Management LLC (together with its affiliates, “Tikvah” or “we”), which owns approximately 1.5% of the outstanding common shares of Quanterix Corp. (Nasdaq: QTRX) (“Quanterix” or the “Company”), today announced that it intends to vote AGAINST the Company’s proposed merger with Akoya Biosciences, Inc. (“Akoya”) (Nasdaq: AKYA) at the upcoming Quanterix Special Meeting of shareholders. As a significant investor in the Company since 2018, Tikvah believes the proposed merger is not in the best interest of Quanterix’s shareholders. Tikvah echoes the public comments made by other investors opposing the merger, including that the proposed transaction undervalues Quanterix’s shares, there would be a significant reduction in the Company’s cash runway post-merger, and that Quanterix’s business is far superior to Akoya’s.

Tikvah reserves the right to change this intention should there be significant new developments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250324019163/en/